Dong Bum Kim

Title: Innovations of Dong Bum Kim in Antibody Development

Introduction

Dong Bum Kim is a notable inventor based in Chuncheon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of two patents to his name, his work focuses on innovative solutions for combating viral infections.

Latest Patents

Dong Bum Kim's latest patents include groundbreaking inventions in the realm of antibodies. The first patent is for an "Antibacterial antibody and use thereof," which describes a monoclonal antibody produced by CpG-DNA. This invention features a polypeptide sequence that includes specific complementarity determining regions (CDRs) for both heavy and light chains. The second patent pertains to a "Monoclonal antibody that binds a MERS-coronavirus." This invention specifically recognizes the spike protein of the MERS coronavirus, showcasing a similar structure with defined CDR sequences.

Career Highlights

Dong Bum Kim is affiliated with the Industry Academic Cooperation Foundation at Hallym University. His work in this institution has allowed him to collaborate with other experts in the field, enhancing the research and development of innovative antibody therapies.

Collaborations

Some of his notable coworkers include Hyung Joo Kwon and Te Ha Kim. Their collaborative efforts contribute to the advancement of research in monoclonal antibodies and their applications in medicine.

Conclusion

Dong Bum Kim's contributions to the field of antibody development highlight his innovative spirit and dedication to addressing critical health challenges. His patents represent significant advancements in biotechnology, particularly in the fight against viral infections.